Related references
Note: Only part of the references are listed.Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma
J. Connor Wells et al.
CLINICAL GENITOURINARY CANCER (2020)
Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells
Chi-Hao Hsiao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
Paulina Marona et al.
CELLS (2019)
Signaling Molecules in Posttransplantation Cancer
Murugabaskar Balan et al.
CLINICS IN LABORATORY MEDICINE (2019)
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1
Samik Chakraborty et al.
ONCOGENESIS (2019)
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
Peter Makhov et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo
Kangmao Huang et al.
CELL DEATH & DISEASE (2018)
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Fabiana Conciatori et al.
CANCERS (2018)
Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network
Ben Sprangers et al.
CLINICAL KIDNEY JOURNAL (2018)
Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells
Akash Sabarwal et al.
MOLECULAR CARCINOGENESIS (2017)
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Toni K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Hanna-Riikka Teppo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells
Chieh-Hsiang Lu et al.
PHARMACOLOGICAL RESEARCH (2017)
Strategies to over come therapeutic resistance in renal cell carcinoma
Peter J. Siska et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
Murugabaskar Balan et al.
SCIENTIFIC REPORTS (2017)
Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States
S. Karami et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
Agnieszka Loboda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death
Kai Wang et al.
SCIENTIFIC REPORTS (2016)
Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression
Murugabaskar Balan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Renal cancer in kidney transplanted patients
Giovanni M. Frasca et al.
JOURNAL OF NEPHROLOGY (2015)
Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function
Jing Pan et al.
CANCER PREVENTION RESEARCH (2014)
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2014)
Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
Enrique Rozengurt et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression
Aninda Basu et al.
CANCER LETTERS (2012)
Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
S. Arora et al.
CURRENT MOLECULAR MEDICINE (2012)
Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
Eric A. Engels et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure-Activity Relationship
Liang Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Signaling pathways in renal cell carcinoma
Gowrishankar Banumathy et al.
CANCER BIOLOGY & THERAPY (2010)
Anti-Inflammatory Bioactivities of Honokiol through Inhibition of Protein Kinase C, Mitogen-Activated Protein Kinase, and the NF-κB Pathway To Reduce LPS-Induced TNFα and NO Expression
Louis Kuoping Chao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation
Martin P. Gallagher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Patient Survival After the Diagnosis of Cancer in Renal Transplant Recipients: A Nested Case-Control Study
Jacqueline van de Wetering et al.
TRANSPLANTATION (2010)
Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
Levi E. Fried et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A164-Driven Angiogenesis, in Part by Blocking S6Kinase
Qi Xue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction
Eun-Ryeong Hahm et al.
CLINICAL CANCER RESEARCH (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Use of sirolimus in solid organ transplantation
Joshua J. Augustine et al.
DRUGS (2007)
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
RH Thompson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Rapamycin in transplantation: A review of the evidence
RN Saunders et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
